EBITDA Margin % is calculated as EBITDA divided by its Revenue. Alere's EBITDA for the
three
months ended in Jun. 2017 was $31.99 Mil. Alere's Revenue for the
three
months ended in Jun. 2017 was $557.67 Mil. Therefore, Alere's EBITDA margin for the quarter that ended in Jun. 2017 was 5.74%.
Alere EBITDA Margin % Historical Data
The historical data trend for Alere's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Alere's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alere's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Alere's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Alere's EBITDA Margin % falls into.
Alere EBITDA Margin % Calculation
EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.
Alere's EBITDA Margin % for the fiscal year that ended in Dec. 2016 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Alere EBITDA Margin % Related Terms
Thank you for viewing the detailed overview of Alere's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Alere, Inc. develops rapid point-of-care diagnostic devices in cardiology, infectious disease, toxicology, diabetes, oncology, and women's health. North America accounts for the largest portion of the firm's revenue (55%), followed by Europe (19%), Asia-Pacific (14%), and the rest of the world (12%). Alere's headquarters are in Waltham, Massachusetts.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ALRPRB.PFD has been successfully added to your 